Annual Net Income
-$55.85 M
-$18.31 M-48.77%
December 1, 2024
Summary
- As of March 12, 2025, ALDX annual net profit is -$55.85 million, with the most recent change of -$18.31 million (-48.77%) on December 1, 2024.
- During the last 3 years, ALDX annual net income has risen by +$1.92 million (+3.33%).
- ALDX annual net income is now -527.64% below its all-time high of $13.06 million, reached on December 31, 2013.
Performance
ALDX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$15.81 M
-$695.80 K-4.60%
December 1, 2024
Summary
- As of March 12, 2025, ALDX quarterly net profit is -$15.81 million, with the most recent change of -$695.80 thousand (-4.60%) on December 1, 2024.
- Over the past year, ALDX quarterly net income has dropped by -$11.06 million (-232.61%).
- ALDX quarterly net income is now -269.82% below its all-time high of $9.31 million, reached on September 30, 2013.
Performance
ALDX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$55.85 M
-$11.06 M-24.68%
December 1, 2024
Summary
- As of March 12, 2025, ALDX TTM net profit is -$55.85 million, with the most recent change of -$11.06 million (-24.68%) on December 1, 2024.
- Over the past year, ALDX TTM net income has dropped by -$18.31 million (-48.77%).
- ALDX TTM net income is now -412.53% below its all-time high of $17.87 million, reached on June 30, 2014.
Performance
ALDX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ALDX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.8% | -232.6% | -48.8% |
| 3 y3 years | +3.3% | -0.3% | +3.3% |
| 5 y5 years | +8.2% | -20.1% | +8.2% |
ALDX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.8% | +9.9% | -232.6% | +11.1% | -86.1% | +15.5% |
| 5 y | 5-year | -48.8% | +9.9% | -232.6% | +11.1% | -86.1% | +15.5% |
| alltime | all time | -527.6% | +9.9% | -269.8% | +27.3% | -412.5% | +15.5% |
Aldeyra Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$55.85 M(+48.8%) | -$15.81 M(+4.6%) | -$55.85 M(+24.7%) |
| Sep 2024 | - | -$15.11 M(-10.3%) | -$44.80 M(+18.3%) |
| Jun 2024 | - | -$16.85 M(+108.5%) | -$37.87 M(+26.2%) |
| Mar 2024 | - | -$8.08 M(+70.0%) | -$30.01 M(-20.1%) |
| Dec 2023 | -$37.54 M(-39.5%) | -$4.75 M(-41.9%) | -$37.54 M(-17.8%) |
| Sep 2023 | - | -$8.19 M(-8.9%) | -$45.69 M(-12.2%) |
| Jun 2023 | - | -$8.99 M(-42.4%) | -$52.06 M(-14.5%) |
| Mar 2023 | - | -$15.62 M(+21.0%) | -$60.85 M(-1.9%) |
| Dec 2022 | -$62.02 M(+7.4%) | -$12.90 M(-11.3%) | -$62.02 M(-4.4%) |
| Sep 2022 | - | -$14.55 M(-18.2%) | -$64.88 M(-1.9%) |
| Jun 2022 | - | -$17.78 M(+5.9%) | -$66.12 M(+4.5%) |
| Mar 2022 | - | -$16.79 M(+6.6%) | -$63.27 M(+9.5%) |
| Dec 2021 | -$57.78 M(+53.8%) | -$15.75 M(-0.3%) | -$57.78 M(+8.4%) |
| Sep 2021 | - | -$15.79 M(+5.7%) | -$53.31 M(+14.9%) |
| Jun 2021 | - | -$14.94 M(+32.3%) | -$46.39 M(+19.0%) |
| Mar 2021 | - | -$11.29 M(-0.0%) | -$38.98 M(+3.8%) |
| Dec 2020 | -$37.55 M(-38.3%) | -$11.29 M(+27.3%) | -$37.55 M(-4.7%) |
| Sep 2020 | - | -$8.87 M(+18.0%) | -$39.42 M(-20.0%) |
| Jun 2020 | - | -$7.52 M(-23.8%) | -$49.26 M(-10.5%) |
| Mar 2020 | - | -$9.87 M(-25.0%) | -$55.07 M(-9.5%) |
| Dec 2019 | -$60.83 M(+56.4%) | -$13.16 M(-29.7%) | -$60.83 M(+4.3%) |
| Sep 2019 | - | -$18.71 M(+40.4%) | -$58.30 M(+15.7%) |
| Jun 2019 | - | -$13.33 M(-14.7%) | -$50.40 M(+9.3%) |
| Mar 2019 | - | -$15.62 M(+46.9%) | -$46.12 M(+18.6%) |
| Dec 2018 | -$38.89 M | -$10.63 M(-1.7%) | -$38.89 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$10.81 M(+19.5%) | -$35.21 M(+19.8%) |
| Jun 2018 | - | -$9.05 M(+7.8%) | -$29.39 M(+14.6%) |
| Mar 2018 | - | -$8.40 M(+20.7%) | -$25.65 M(+14.8%) |
| Dec 2017 | -$22.34 M(+19.5%) | -$6.95 M(+39.5%) | -$22.34 M(+11.5%) |
| Sep 2017 | - | -$4.99 M(-6.1%) | -$20.04 M(+1.1%) |
| Jun 2017 | - | -$5.31 M(+4.3%) | -$19.83 M(+5.3%) |
| Mar 2017 | - | -$5.09 M(+9.5%) | -$18.82 M(+0.7%) |
| Dec 2016 | -$18.70 M(+54.7%) | -$4.65 M(-2.6%) | -$18.70 M(+1.6%) |
| Sep 2016 | - | -$4.78 M(+11.0%) | -$18.40 M(+8.3%) |
| Jun 2016 | - | -$4.30 M(-13.4%) | -$16.99 M(+13.9%) |
| Mar 2016 | - | -$4.97 M(+14.0%) | -$14.92 M(+23.4%) |
| Dec 2015 | -$12.09 M(+133.1%) | -$4.36 M(+29.4%) | -$12.09 M(+18.8%) |
| Sep 2015 | - | -$3.37 M(+50.8%) | -$10.18 M(+15.4%) |
| Jun 2015 | - | -$2.23 M(+4.5%) | -$8.82 M(+14.2%) |
| Mar 2015 | - | -$2.14 M(-12.6%) | -$7.73 M(+48.9%) |
| Dec 2014 | -$5.19 M(-139.7%) | -$2.44 M(+21.7%) | -$5.19 M(-179.2%) |
| Sep 2014 | - | -$2.01 M(+77.0%) | $6.55 M(-63.3%) |
| Jun 2014 | - | -$1.14 M(-382.5%) | $17.87 M(+2.5%) |
| Mar 2014 | - | $401.80 K(-95.7%) | $17.44 M(+33.5%) |
| Dec 2013 | $13.06 M(-156.6%) | $9.30 M(-0.1%) | $13.06 M(-172.7%) |
| Sep 2013 | - | $9.31 M(-693.4%) | -$17.98 M(-34.1%) |
| Jun 2013 | - | -$1.57 M(-60.5%) | -$27.29 M(+6.1%) |
| Mar 2013 | - | -$3.97 M(-81.7%) | -$25.72 M(+18.3%) |
| Dec 2012 | -$23.07 M(+870.3%) | -$21.74 M | -$21.74 M |
| Dec 2011 | -$2.38 M | - | - |
FAQ
- What is Aldeyra Therapeutics annual net profit?
- What is the all time high annual net income for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual net income year-on-year change?
- What is Aldeyra Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly net income year-on-year change?
- What is Aldeyra Therapeutics TTM net profit?
- What is the all time high TTM net income for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics TTM net income year-on-year change?
What is Aldeyra Therapeutics annual net profit?
The current annual net income of ALDX is -$55.85 M
What is the all time high annual net income for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual net profit is $13.06 M
What is Aldeyra Therapeutics annual net income year-on-year change?
Over the past year, ALDX annual net profit has changed by -$18.31 M (-48.77%)
What is Aldeyra Therapeutics quarterly net profit?
The current quarterly net income of ALDX is -$15.81 M
What is the all time high quarterly net income for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly net profit is $9.31 M
What is Aldeyra Therapeutics quarterly net income year-on-year change?
Over the past year, ALDX quarterly net profit has changed by -$11.06 M (-232.61%)
What is Aldeyra Therapeutics TTM net profit?
The current TTM net income of ALDX is -$55.85 M
What is the all time high TTM net income for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high TTM net profit is $17.87 M
What is Aldeyra Therapeutics TTM net income year-on-year change?
Over the past year, ALDX TTM net profit has changed by -$18.31 M (-48.77%)